Treatment of Indoleamine 2,3-dioxygenase shRNA Has Therapeutic Efficacy in an Orthotopic Hepatoma Model
碩士 === 國立成功大學 === 生物化學研究所 === 97 === Hepatocellular carcinoma (HCC, also called hepatoma) is one of the most prevalent malignancies in the world, and the prognosis of hepatoma is poor. There is accumulating evidence showing that tumor specific tolerance influences tumor progression. Indoleamine 2,3-...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | en_US |
| Published: |
2009
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/40722356911331997110 |